Improving opioid treatment quality and jail-to-community care connections for people leaving jail
Official title: Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
Run by University of Washington · NCT06593353 · Data updated 2026-11-12
This project will test whether a package of systems-engineering tools (SAIA) helps jails and community clinics connect people leaving jail to medications for opioid use disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 4186 (estimated) |
| Sponsor | University of Washington Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | November 21, 2024 |
| Main results expected | March 31, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT06593353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants include adults (18+) receiving MOUD in King County jails who are on Medicaid and are released to the community, plus clinic staff and community patients with recent jail involvement for the implementation evaluations.
✕Probably not a fit
People not on Medicaid, those located outside King County, or individuals who do not receive MOUD while incarcerated are unlikely to be included or to receive direct benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will implement the Systems Analysis and Improvement Approach (SAIA), a bundled set of systems-engineering tools, at one jail-based MOUD program and three community referral clinics in King County, WA over three years (two years intensive, one year sustainment). Outcomes include linkage to community-based MOUD within 30 days of jail release and a secondary measure of early retention (return for a second MOUD pickup within 30 days). Investigators will use de-identified clinical data to measure effectiveness, conduct qualitative interviews with staff guided by CFIR and FRAME-IS to study adoption and adaptations, and estimate costs and cost-effectiveness of the implementation strategy. The study combines quantitative cascade analysis, flow mapping, and continuous quality improvement cycles to optimize service delivery and handoffs between jail and community providers.
Why it matters
Potential benefit: If successful, the approach could increase timely connections to MOUD after jail release and improve short-term treatment retention for people with opioid use disorder.
How similar studies have gone: SAIA is an evidence-based implementation approach that has improved care cascades in other health areas, but applying it specifically to jail-to-community MOUD linkage is a newer application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Implementation Outcomes (consented) Group 1: * clinic staff/providers at study clinics (JHS, OBOT, Pathways, Sound) * age 18+ Group 2: * current patients at SAIA clinic in the community (OBOT, Pathways, Sound) with jail involvement in the last 12 months * age 18+ Clinical Outcomes (de-identified data, non consented) Group 3: * receive MOUD treatment while incarcerated in King County Jails (WA). * age 18+ * on Medicaid * released to community Exclusion Criteria: Group 1 \& 2: * do not consent Group 3: * not on Medicaid
Where it's running
-
University of Washington
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Sarah Odell Gimbel-Sherr — University of Washington
- Study coordinator: Sarah Odell Gimbel-Sherr
- Email: sgimbel@uw.edu
- Phone: 206 291 4223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
STORC: Training a support person plus patient navigation after birth
We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.
-
Personalized Addiction Treatment Enhancement for Opioid Use Disorder
A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.